Bruce I. Sachs, a director at Vertex Pharmaceuticals (VRTX), made two open market purchases of company shares worth about $1.95 million over the past year. His most recent buy occurred on August 6, 2025. These purchases rank him 335th among nearly 5,000 insiders by total amount bought, above the average of $1.46 million across about 3.3 transactions per insider. Sachs reported no open market sales in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 15, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | SACHS BRUCE I | Director | A | Deferred Stock Units | 107 | $443.56 | 15,564.5210 | 258,000,000 | 0.69% | 0.00% |
| Oct. 15, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | SACHS BRUCE I | Director | A | Deferred Stock Units | 116 | $410.31 | 15,457.4330 | 258,600,000 | 0.75% | 0.00% |
| Aug. 6, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | SACHS BRUCE I | Director | P | Common Stock | 1634 | $389.36 | 41,634.0000 | 257,899,999 | 4.09% | 0.00% |
| Aug. 6, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | SACHS BRUCE I | Director | P | Common Stock | 3366 | $389.84 | 45,000.0000 | 257,899,999 | 8.08% | 0.00% |
| July 15, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | SACHS BRUCE I | Director | A | Deferred Stock Units | 101 | $469.34 | 15,341.6670 | 257,899,999 | 0.66% | 0.00% |
| May 1, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | SACHS BRUCE I | Director | A | Stock Option (Right to Buy) | 2398 | $0.00 | 2,398.0000 | 257,899,999 | 9999.99% | 0.00% |
| April 15, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | SACHS BRUCE I | Director | A | Deferred Stock Units | 95 | $497.51 | 15,240.4610 | 257,899,999 | 0.63% | 0.00% |
| Jan. 15, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | SACHS BRUCE I | Director | A | Deferred Stock Units | 112 | $420.31 | 15,144.9860 | 257,899,999 | 0.74% | 0.00% |
| Oct. 15, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | SACHS BRUCE I | Director | A | Deferred Stock Units | 90 | $484.39 | 15,033.3320 | 261,000,000 | 0.60% | 0.00% |
| Aug. 1, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | SACHS BRUCE I | Director | M | Stock Option (Right to Buy) | 5295 | $0.00 | 0.0000 | 260,500,000 | 100.00% | 0.00% |
| Aug. 1, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | SACHS BRUCE I | Director | M | Common Stock | 5295 | $125.71 | 45,295.0000 | 260,500,000 | 13.24% | 0.00% |
| Aug. 1, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | SACHS BRUCE I | Director | S | Common Stock | 5295 | $508.00 | 40,000.0000 | 260,500,000 | 11.69% | 0.00% |
| July 15, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | SACHS BRUCE I | Director | A | Deferred Stock Units | 89 | $490.12 | 14,943.0120 | 260,500,000 | 0.60% | 0.00% |
| May 22, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | SACHS BRUCE I | Director | M | Common Stock | 7073 | $93.51 | 47,073.0000 | 260,500,000 | 17.68% | 0.00% |
| May 22, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | SACHS BRUCE I | Director | M | Stock Option (Right to Buy) | 7073 | $0.00 | 0.0000 | 260,500,000 | 100.00% | 0.00% |
| May 22, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | SACHS BRUCE I | Director | S | Common Stock | 7073 | $448.00 | 40,000.0000 | 260,500,000 | 15.03% | 0.00% |
| May 1, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | SACHS BRUCE I | Director | A | Stock Option (Right to Buy) | 3142 | $0.00 | 3,142.0000 | 260,500,000 | 9999.99% | 0.00% |
| April 15, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | SACHS BRUCE I | Director | A | Deferred Stock Units | 109 | $399.58 | 14,853.7480 | 260,500,000 | 0.74% | 0.00% |
| Jan. 12, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | SACHS BRUCE I | Director | A | Deferred Stock Units | 101 | $432.99 | 14,744.2580 | 260,500,000 | 0.69% | 0.00% |